Stock listing
BOATS:CADL Candel Therapeutics, Inc. Stock
US listing (BOATS) of Candel Therapeutics, Inc. · home listing NASDAQ:CADL
Follow Candel Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CADL
$8.12 USD -0.21 (-2.5%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CADL
- Day range
- $8.01 – $8.61 USDNov 2, 2026
- Volume
- 862,000 sharesNov 2, 2026
- Market cap
- $621.3M USDAt the close on Nov 2, 2026 · price × 76.52M shares outstanding
- 52-week range
- $4.35 – $14.00 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $12.33M USDMedian day 977,769 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CADL · Home | $8.12 USD | -0.21 (-2.5%) | 862,000 | $8.35 | $8.61 | $8.011 | $8.33 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CADL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.12 | -0.21 | -2.5% | $8.35 | $8.61 | $8.011 | 862,000 | |
| $8.33 | -0.32 | -3.7% | $8.56 | $8.61 | $8.16 | 779,842 | |
| $8.65 | -0.02 | -0.2% | $8.72 | $8.93 | $8.553 | 740,851 | |
| $8.67 | +0.42 | +5.1% | $8.13 | $8.69 | $8.13 | 663,858 | |
| $8.25 | +0.46 | +5.9% | $7.78 | $8.37 | $7.741 | 928,458 | |
| $7.79 | -0.24 | -3.0% | $8.44 | $8.44 | $7.70 | 849,052 | |
| $8.03 | -0.35 | -4.2% | $8.33 | $8.33 | $7.905 | 1,184,816 | |
| $8.38 | +0.01 | +0.1% | $8.45 | $8.79 | $8.255 | 762,579 | |
| $8.37 | -0.27 | -3.1% | $8.65 | $8.82 | $8.35 | 1,102,647 | |
| $8.64 | +0.43 | +5.2% | $8.17 | $8.84 | $8.125 | 1,126,151 | |
| $8.21 | +0.02 | +0.2% | $8.37 | $8.499 | $7.96 | 1,278,696 | |
| $8.19 | -0.72 | -8.1% | $8.92 | $8.92 | $8.125 | 1,513,092 | |
| $8.91 | -0.16 | -1.8% | $9.01 | $9.10 | $8.79 | 989,338 | |
| $9.07 | -0.20 | -2.2% | $9.06 | $9.43 | $9.03 | 989,443 | |
| $9.27 | -0.51 | -5.2% | $9.78 | $9.845 | $9.22 | 1,133,162 | |
| $9.78 | -0.16 | -1.6% | $10.00 | $10.18 | $9.71 | 744,631 | |
| $9.94 | +0.28 | +2.9% | $9.69 | $9.95 | $9.59 | 718,368 | |
| $9.66 | -0.16 | -1.6% | $9.70 | $9.755 | $9.45 | 888,496 | |
| $9.82 | -0.05 | -0.5% | $9.75 | $9.945 | $9.60 | 714,954 | |
| $9.87 | -0.36 | -3.5% | $10.32 | $10.40 | $9.85 | 977,769 | |
| $10.23 | +0.05 | +0.5% | $10.27 | $10.45 | $9.94 | 980,886 | |
| $10.18 | +0.02 | +0.2% | $10.29 | $10.37 | $10.03 | 878,803 | |
| $10.16 | -0.28 | -2.7% | $10.72 | $10.72 | $10.16 | 1,037,610 | |
| $10.44 | -0.44 | -4.0% | $11.02 | $11.25 | $10.37 | 1,268,853 | |
| $10.88 | -0.31 | -2.8% | $11.25 | $11.25 | $10.57 | 963,288 | |
| $11.19 | +0.17 | +1.5% | $10.98 | $11.52 | $10.76 | 771,016 | |
| $11.02 | -0.53 | -4.6% | $11.50 | $11.55 | $11.01 | 799,764 | |
| $11.55 | +0.26 | +2.3% | $11.22 | $11.59 | $10.85 | 883,107 | |
| $11.29 | -0.56 | -4.7% | $11.93 | $12.01 | $11.27 | 1,287,820 | |
| $11.85 | +0.64 | +5.7% | $11.28 | $11.96 | $11.15 | 882,043 | |
| $11.21 | +0.36 | +3.3% | $11.85 | $11.90 | $11.13 | 1,086,919 | |
| $10.85 | -0.49 | -4.3% | $11.28 | $11.38 | $10.78 | 3,014,534 | |
| $11.34 | +0.32 | +2.9% | $10.95 | $11.50 | $10.86 | 798,618 | |
| $11.02 | -0.10 | -0.9% | $11.16 | $11.43 | $10.83 | 1,168,698 | |
| $11.12 | +0.445 | +4.2% | $10.63 | $11.14 | $10.41 | 1,065,387 | |
| $10.68 | +0.13 | +1.2% | $10.41 | $10.97 | $10.32 | 940,804 | |
| $10.55 | -0.785 | -6.9% | $11.32 | $11.41 | $9.855 | 3,596,201 | |
| $11.33 | -0.84 | -6.9% | $12.05 | $12.05 | $11.20 | 1,952,924 | |
| $12.17 | -0.43 | -3.4% | $12.52 | $12.78 | $12.13 | 661,253 | |
| $12.60 | -0.18 | -1.4% | $12.57 | $12.85 | $12.02 | 1,002,103 | |
| $12.78 | -0.19 | -1.5% | $12.91 | $13.05 | $12.76 | 535,822 | |
| $12.97 | -0.23 | -1.7% | $13.21 | $13.28 | $12.73 | 628,312 | |
| $13.20 | +0.35 | +2.7% | $12.81 | $13.41 | $12.67 | 807,852 | |
| $12.85 | -0.22 | -1.7% | $12.93 | $13.04 | $12.60 | 935,641 | |
| $13.07 | 0.00 | 0.0% | $13.02 | $13.22 | $12.63 | 895,013 | |
| $13.07 | -0.68 | -4.9% | $13.64 | $13.80 | $12.88 | 1,236,463 | |
| $13.75 | +0.47 | +3.5% | $13.26 | $14.00 | $13.20 | 1,185,355 | |
| $13.28 | -0.32 | -2.4% | $13.60 | $13.85 | $13.19 | 977,998 | |
| $13.60 | +0.74 | +5.8% | $13.09 | $13.95 | $12.97 | 1,342,938 | |
| $12.86 | -0.27 | -2.1% | $12.99 | $12.99 | $12.40 | 959,088 | |
| $13.13 | +0.78 | +6.3% | $12.52 | $13.26 | $12.38 | 1,339,298 | |
| $12.35 | -1.15 | -8.5% | $13.23 | $13.38 | $12.33 | 1,541,934 | |
| $13.50 | +1.45 | +12.0% | $12.42 | $13.82 | $12.28 | 2,376,815 | |
| $12.05 | -0.11 | -0.9% | $12.03 | $12.15 | $11.77 | 786,870 | |
| $12.16 | +0.44 | +3.8% | $11.49 | $12.49 | $11.11 | 2,160,898 | |
| $11.72 | -0.08 | -0.7% | $11.85 | $11.95 | $11.04 | 2,069,292 | |
| $11.80 | +1.12 | +10.5% | $10.85 | $11.87 | $10.48 | 2,152,443 | |
| $10.68 | +0.03 | +0.3% | $10.71 | $10.90 | $10.50 | 1,378,941 | |
| $10.65 | +0.15 | +1.4% | $10.58 | $10.69 | $10.41 | 857,172 | |
| $10.50 | -0.09 | -0.8% | $10.50 | $10.66 | $10.35 | 648,486 | |
| $10.59 | +0.01 | +0.1% | $10.69 | $10.74 | $10.52 | 800,789 | |
| $10.58 | +0.12 | +1.1% | $10.47 | $10.80 | $10.42 | 1,298,231 | |
| $10.46 | -0.05 | -0.5% | $10.57 | $10.82 | $10.28 | 750,662 | |
| $10.51 | +0.44 | +4.4% | $10.15 | $10.52 | $10.09 | 1,072,773 | |
| $10.07 | +0.06 | +0.6% | $9.97 | $10.18 | $9.51 | 879,390 |
- Ticker
- BOATS:CADL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 73 slides
Latest news
Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer
Oct 29, 2026
Closed $8.65 (-0.2%) on Oct 29, 2026
Candel Therapeutics to Present at November Investor Conferences
Oct 27, 2026
Closed $8.25 (+5.9%) on Oct 27, 2026
Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
Oct 22, 2026
Closed $8.38 (+0.1%) on Oct 22, 2026
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
Oct 2, 2026
Closed $10.18 (+0.2%) on Oct 2, 2026
Candel Therapeutics Announces Publication of Phase 2a Trial Data that Demonstrated Prolonged Survival after Systemic Immune Reactivation by Aglatimagene Besadenovec plus Valacyclovir in Patients with Unresectable Stage III/IV NSCLC with an Inadequate Response to ICI
Oct 1, 2026
Closed $10.16 (-2.7%) on Oct 1, 2026
Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer
Sep 30, 2026
Closed $10.44 (-4.0%) on Sep 30, 2026
Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026
Sep 30, 2026
Closed $10.44 (-4.0%) on Sep 30, 2026
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
Sep 10, 2026
Closed $11.33 (-6.9%) on Sep 10, 2026
Candel Therapeutics to Present at September Investor Conferences
Aug 26, 2026
Closed $13.28 (-2.4%) on Aug 26, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 73 slides · September 2026
Corporate Update (May 2026)
Corporate update · 23 slides · May 15, 2026
AUA 2026
Conference · 17 slides · May 2026
Investor Day (December 2025)
Investor day · 80 slides · Dec 5, 2025
Candel Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 37 in the last 12 months · 130 in all · newest Nov 2, 2026 · oldest 2021
- Decks
- 13 decks · latest September 2026
Where Candel Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CADL · Home listing | NASDAQ | United States | USD |
| BOATS:CADL · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Candel Therapeutics, Inc.